Search Results

By Gregory Bociek, MD, MSc  / October 25, 2021

BTK Inhibition in CLL: An Embarrassment of Riches

Chronic lymphocytic leukemia (CLL) is a B-cell lymphoproliferative disorder defined by a specific phenotype and the presence of more than 5,000 clonal B cells in the peripheral blood.1 In the absence of this number of circulating cells, its soft-tissue/bone-marrow counterpart is semantically...